James Fang MD
James Chen-Tson Fang, M.D., is the Chief of Cardiovascular Medicine at the University of Utah School of Medicine and the Director of the Cardiovascular Service Line at University of Utah Health Care. He holds the John and June B. Hartman Presidential Endowed Chair and is a Professor of Medicine at the University of Utah School of Medicine.
Dr. Fang graduated from Duke University in 1984 with a major in Mathematics and a minor in Chemistry, and he earned his medical degree from the Duke University School of Medicine in 1988. He completed his internship and residency at Johns Hopkins Hospital in 1991, where he was later selected as an Assistant Chief of Service (Chief Resident) in 1993. He completed his cardiovascular and heart failure/transplant fellowships at Brigham and Women’s Hospital/Harvard Medical School in 1996 and 1997, respectively.
His first faculty appointment was at Brigham and Women’s Hospital/Harvard Medical School in 1997, where he remained until 2006. During his tenure in Boston, he served as Associate Professor of Medicine, Medical Director of the Heart Transplant Program, and Program Director of the Cardiovascular Fellowship Training Program.
In 2006, Dr. Fang was recruited to University Hospitals/Case Western Reserve University School of Medicine in Cleveland, where he served as Clinical Chief of Cardiovascular Medicine, Associate Chief for Clinical Affairs, Medical Director of the Heart Failure, Transplant, and Circulatory Assist Program, and Chief Medical Officer for the Harrington Heart and Vascular Institute. He also held the Spitz Master Clinician Chair at Case Western Reserve University School of Medicine, where he was a Professor of Medicine.
In 2013, he assumed the role of Chief of Cardiovascular Medicine at the University of Utah and became the Executive Director of UU Health’s Cardiovascular Service Line. In this position, Dr. Fang leads efforts to establish the institution as a premier clinical, educational, and research center for cardiovascular disease. He focuses on developing highly skilled multidisciplinary teams that provide comprehensive, personalized, and cost-effective care, and oversees the research, education, and clinical care programs of the Cardiovascular Division.
A highly regarded clinician, teacher, mentor, and researcher, Dr. Fang is the author of more than 175 original articles, editorials, and book chapters and has lectured nationally and internationally. He has been involved in several significant cardiovascular research groups and collaborations, with special interests in heart failure with preserved ejection fraction, advanced heart failure, coronary artery vasculopathy of the transplanted heart, and cardiorenal syndrome. He has led multiple position statements for the Heart Failure Society of America and the International Society for Heart and Lung Transplantation. Currently, he serves on the ACC/AHA Heart Failure Guideline Committee and the Board of Directors of the Heart Failure Society of America. In 2013, he was elected to the Association of University Cardiologists and is a member of the Executive Committee of the Association of Professors of Cardiology.